JP2023515539A - 外用ジクロフェナク組成物及び方法 - Google Patents

外用ジクロフェナク組成物及び方法 Download PDF

Info

Publication number
JP2023515539A
JP2023515539A JP2022550963A JP2022550963A JP2023515539A JP 2023515539 A JP2023515539 A JP 2023515539A JP 2022550963 A JP2022550963 A JP 2022550963A JP 2022550963 A JP2022550963 A JP 2022550963A JP 2023515539 A JP2023515539 A JP 2023515539A
Authority
JP
Japan
Prior art keywords
diclofenac
amount
composition
topical
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022550963A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515539A5 (https=
Inventor
ダリオ エヌ アール カラーラ
アルノー グルニエ
Original Assignee
フェリング ベスローテン フェンノートシャップ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フェリング ベスローテン フェンノートシャップ filed Critical フェリング ベスローテン フェンノートシャップ
Publication of JP2023515539A publication Critical patent/JP2023515539A/ja
Publication of JP2023515539A5 publication Critical patent/JP2023515539A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2022550963A 2020-02-27 2021-02-25 外用ジクロフェナク組成物及び方法 Pending JP2023515539A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062982589P 2020-02-27 2020-02-27
US62/982,589 2020-02-27
PCT/NL2021/050125 WO2021172987A1 (en) 2020-02-27 2021-02-25 Topical diclofenac compositions and methods

Publications (2)

Publication Number Publication Date
JP2023515539A true JP2023515539A (ja) 2023-04-13
JP2023515539A5 JP2023515539A5 (https=) 2024-03-01

Family

ID=74858737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550963A Pending JP2023515539A (ja) 2020-02-27 2021-02-25 外用ジクロフェナク組成物及び方法

Country Status (9)

Country Link
US (1) US20230157979A1 (https=)
EP (1) EP4110320A1 (https=)
JP (1) JP2023515539A (https=)
CN (1) CN115279360A (https=)
AU (1) AU2021228521A1 (https=)
BR (1) BR112022016887A2 (https=)
CA (1) CA3169241A1 (https=)
MX (1) MX2022010593A (https=)
WO (1) WO2021172987A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015522049A (ja) * 2012-07-12 2015-08-03 フェリング ベスローテン フェンノートシャップ ジクロフェナク製剤
JP2016505282A (ja) * 2012-10-22 2016-02-25 ヌーボ リサーチ インコーポレイテッドＮｕｖｏ Ｒｅｓｅａｒｃｈ Ｉｎｃ． 分注システム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE534373T1 (de) 2003-10-10 2011-12-15 Antares Pharma Ipl Ag Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
EP2654638A4 (en) * 2010-12-20 2014-07-02 Polytherapeutics Inc COMPOSITION FOR TRANSDERMAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG
WO2013014680A1 (en) * 2011-07-28 2013-01-31 Cadila Healthcare Limited Method for treatment of pain and inflammation
US9468618B2 (en) * 2014-12-12 2016-10-18 Lupin Atlantis Holdings Sa Topical pharmaceutical gel composition of diclofenac sodium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015522049A (ja) * 2012-07-12 2015-08-03 フェリング ベスローテン フェンノートシャップ ジクロフェナク製剤
JP2016505282A (ja) * 2012-10-22 2016-02-25 ヌーボ リサーチ インコーポレイテッドＮｕｖｏ Ｒｅｓｅａｒｃｈ Ｉｎｃ． 分注システム

Also Published As

Publication number Publication date
CA3169241A1 (en) 2021-09-02
US20230157979A1 (en) 2023-05-25
BR112022016887A2 (pt) 2022-10-18
AU2021228521A1 (en) 2022-10-13
MX2022010593A (es) 2022-12-13
CN115279360A (zh) 2022-11-01
EP4110320A1 (en) 2023-01-04
WO2021172987A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
JP6434104B2 (ja) ジクロフェナク製剤
US8647665B2 (en) Methods of treating hot flashes with formulations for transdermal or transmucosal application
JP2023109969A (ja) 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
AU2019203449B2 (en) Topical diclofenac sodium compositions
JP2015530380A (ja) 乾癬を治療するための組成物
US20180344640A1 (en) Econazole composition and methods of treatment therewith
US9468618B2 (en) Topical pharmaceutical gel composition of diclofenac sodium
JP2023515539A (ja) 外用ジクロフェナク組成物及び方法
RU2830586C1 (ru) Композиции на основе диклофенака для местного применения и связанные с ними способы
CN121152629A (zh) 药物组合物
US9687549B2 (en) Topical pharmaceutical gel composition of diclofenac sodium
US20240024273A1 (en) Topical administration of 2-(diethylamino)ethyl 2-(4-isobutylphenyl)proprionate for treatment of diseases
US20160263065A1 (en) Topical pharmaceutical gel composition of diclofenac sodium

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240221

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250325

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250924

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260311